Cite
HARVARD Citation
Venner, C. et al. (2021). Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial. American journal of hematology. 96 (5), pp. 552-560. [Online].